Literature DB >> 15232578

Novel therapeutic approaches for heart failure by normalizing calcium cycling.

Xander H T Wehrens1, Andrew R Marks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15232578     DOI： 10.1038/nrd1440

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  30 in total

1.  Mitofusin 2-containing mitochondrial-reticular microdomains direct rapid cardiomyocyte bioenergetic responses via interorganelle Ca(2+) crosstalk.

Authors:  Yun Chen; György Csordás; Casey Jowdy; Timothy G Schneider; Norbert Csordás; Wei Wang; Yingqiu Liu; Michael Kohlhaas; Maxie Meiser; Stefanie Bergem; Jeanne M Nerbonne; Gerald W Dorn; Christoph Maack
Journal:  Circ Res       Date:  2012-07-09       Impact factor: 17.367

2.  ACE inhibition prevents diastolic Ca2+ overload and loss of myofilament Ca2+ sensitivity after myocardial infarction.

Authors:  S Zalvidea; L André; X Loyer; C Cassan; Y Sainte-Marie; J Thireau; I Sjaastad; C Heymes; J-L Pasquié; O Cazorla; F Aimond; S Richard
Journal:  Curr Mol Med       Date:  2012-02       Impact factor: 2.222

Review 3.  [Reverse remodeling of the intracellular Ca(2+)-homeostasis: new concepts of pathophysiology and therapy of heart failure].

Authors:  Klara Brixius; Konrad F Frank; Birgit Bölck; Felix Hoyer; Robert H G Schwinger
Journal:  Wien Med Wochenschr       Date:  2006-04

Review 4.  The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms?

Authors:  Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2006-12-15       Impact factor: 6.343

5.  Enhanced ryanodine receptor-mediated calcium leak determines reduced sarcoplasmic reticulum calcium content in chronic canine heart failure.

Authors:  Andriy Belevych; Zuzana Kubalova; Dmitry Terentyev; Robert L Hamlin; Cynthia A Carnes; Sandor Györke
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

6.  Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect.

Authors:  Adelino F Leite-Moreira; Paulo Castro-Chaves; Pedro Pimentel-Nunes; Alexandre Lima-Carneiro; Miguel S Guerra; João Bruno Soares; João Ferreira-Martins
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

7.  Differential effects of S100 proteins A2 and A6 on cardiac Ca(2+) cycling and contractile performance.

Authors:  Wang Wang; Michelle L Asp; Guadalupe Guerrero-Serna; Joseph M Metzger
Journal:  J Mol Cell Cardiol       Date:  2014-03-11       Impact factor: 5.000

8.  Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling.

Authors:  Jiali Nie; Quanlu Duan; Mengying He; Xianqing Li; Bei Wang; Chi Zhou; Lujin Wu; Zheng Wen; Chen Chen; Dao Wu Wang; Katherina M Alsina; Xander H T Wehrens; Dao Wen Wang; Li Ni
Journal:  J Cell Physiol       Date:  2018-11-29       Impact factor: 6.384

Review 9.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

Review 10.  Pharmacological characteristics and clinical applications of K201.

Authors:  Noboru Kaneko; Ryuko Matsuda; Yoshihito Hata; Ken Shimamoto
Journal:  Curr Clin Pharmacol       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.